Very low density lipoprotein, chylomicron, and lipoprotein (a) are more useful to detect the development of macrophage activation syndrome in adult-onset still's disease as compared with cytokines and triglyceride

American Journal of Hematology

Volumn 88, Issue 9, 2013, Pages 828-830

  Yanai, Hidekatsu ^a   Moriyama, Sumie ^a   Hirowatari, Yuji ^b   Kaneko, Hiroshi ^a  

^a 1 7 1 Kohnodai   (Japan)

^b TOSOH CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHYLOMICRON; CYTOKINE; FERRITIN; LACTATE DEHYDROGENASE; LIPOPROTEIN; METHYLPREDNISOLONE; PREDNISOLONE; TOCILIZUMAB; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ADULT ONSET STILL DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANION EXCHANGE CHROMATOGRAPHY; ARTHRALGIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CYTOKINE PRODUCTION; FERRITIN BLOOD LEVEL; FEVER; HEPATOSPLENOMEGALY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL ADMISSION; HUMAN; IMMUNOREACTIVITY; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOCYTOSIS; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE ACTIVATION SYNDROME; MALE; NEUTROPHILIA; PATIENT REFERRAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CHYLOMICRONS; CYTOKINES; FERRITINS; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS, VLDL; MACROPHAGE ACTIVATION SYNDROME; MALE; STILL'S DISEASE, ADULT-ONSET; TRIGLYCERIDES;

EID: 84882705983     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23517     Document Type: Letter

References (6)

1. Gianella S, Schaer DJ, Schwarz U, et al. Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome. Am J Hematol 2008;83:424-427.
2. Okamoto M, Yamaguchi H, Isobe Y, et al. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Intern Med 2009;48:775-781.
3. Emmenegger U, Frey U, Reimers A, et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 2001;68:4-10.
4. Hirowatari Y, Yoshida H, Kurosawa H, et al. Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J Lipid Res 2003;44:1404-1412.
5. Bagby GJ, Spitzer JA. Lipoprotein lipase activity in rat heart and adipose tissue during endotoxic shock. Am J Physiol 1980;238:H325-H330.
6. Dangas G, Mehran R, Harpel PC, et al. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol 1998;32:2035-2042.